Evidence map›Paper›PMID 11139513›Full record

ArticleGenetics2001

Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat.

H Lan, C M Kendziorski, J D Haag, L A Shepel, M A Newton, M N Gould

Abstract read
In one paragraph

Article in Genetics, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Mapping Mammary Tumor Traits in the Rat.Methods in molecular biology (Clifton, N.J.) · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Robust QTL Mapping Procedure.Journal of statistical planning and inference · 2009
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

H LanMcArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53792, USA.
C M Kendziorski
J D Haag
L A Shepel
M A Newton
M N Gould
University of Wisconsin–Madison · US

Funding

WKY RAT GENETIC MODEL FOR BREAST CANCER SUSCEPTIBILITYR01CA077494 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI GOULD, MICHAEL N · 1998 to 2012
$3.7M
TRAINING IN CANCER BIOSTATISTICST32CA009565 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI NEWTON, MICHAEL A · 1988 to 2003
$622k
NCI NIH HHS CA 77494NCI NIH HHS TA-CA 09565
6 · The paper itself

Abstract

In this study, the Wistar-Kyoto (WKy) rat was genetically characterized for loci that modify susceptibility to mammary carcinogenesis. We used a genetic backcross between resistant WKy and susceptible Wistar-Furth (WF) rats as a panel for linkage mapping to genetically identify mammary carcinoma susceptibility (Mcs) loci underlying the resistance of the WKy rat. Rats were phenotyped for DMBA-induced mammary carcinomas and genotyped using microsatellite markers. To detect quantitative trait loci (QTL), we analyzed the genome scan data under both parametric and nonparametric distributional assumptions and used permutation tests to calculate significance thresholds. A generalized linear model analysis was also performed to test for interactions between significant QTL. This methodology was extended to identify interactions between the significant QTL and other genome locations. Chromosomes 5, 7, 10, and 14 were found to contain significant QTL, termed Mcs5, Mcs6, Mcs7, and Mcs8, respectively. The WKy alleles of Mcs5, -6, and -8 are associated with mammary carcinoma resistance; the WKy allele of Mcs7 is associated with an increased incidence of mammary cancer. In addition, we identified an interaction between Mcs8 and a region on chromosome 6 termed Mcsm1 (modifier of Mcs), which had no significant main effect on mammary cancer susceptibility in this genetic analysis.

Indexed as

Genes, Tumor SuppressorOncogenes9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogensCrosses, GeneticFemaleGenotypeHumansMaleMammary Neoplasms, ExperimentalModels, GeneticQuantitative Trait, HeritableRatsRats, Inbred WFRats, Inbred WKY9,10-Dimethyl-1,2-benzanthraceneCarcinogens

Identifiers

PMID11139513
PMCPMC1461476
OpenAlexW2098889603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.